---
layout: minimal-medicine
title: Aclarubicin
---

# Aclarubicin
### Generic Name
Aclarubicin

### Usage
Aclarubicin, also known as aclacinomycin A, is an anthracycline antibiotic used in cancer treatment.  While it was once investigated as a monotherapy for various cancers like breast, thyroid, and gastrointestinal adenocarcinomas, its use in this manner is largely discontinued outside of Japan, India, and China due to modest benefits compared to other anthracyclines.  Its primary current use is in combination with other anticancer drugs.  This combination therapy is most notably employed in treating acute myeloid leukemia (AML).  Specific combinations frequently include cytarabine and other agents such as etoposide, granulocyte colony-stimulating factor (G-CSF), prednisolone, gefitinib, cisplatin, or mitomycin C.

### Dosage
Dosage varies significantly depending on the specific treatment regimen and the patient's condition.  The information below is not exhaustive and should not be interpreted as a prescription.  **Always follow your doctor's instructions.**

* **Acute Myeloid Leukemia (AML):**  One common regimen involves intravenous (IV) administration of aclarubicin in combination with other drugs.  For example, a CAG regimen might use aclarubicin at 14 mg/m²/day IV from days 1-4, or 7 mg/m²/day IV from days 1-8, along with low-dose cytarabine and G-CSF administered subcutaneously.  The exact dosages and durations of the other medications in the regimen are crucial and must be determined by the treating physician.  Post-remission chemotherapy often involves additional cycles of this regimen followed by maintenance therapy.


* **Pediatric Dosage:**  The safety and efficacy of aclarubicin in pediatric populations have not been established.

* **Dosage Adjustments:**  The manufacturer's labeling does not offer specific dosage adjustments for hepatic or renal impairment, recommending caution in patients with these conditions.  Adjustments will be at the discretion of the attending physician based on the patient's specific health status and response to the drug.

### Side Effects
Common side effects can include:

* Nausea
* Vomiting
* Mucositis (inflammation of the mucous membranes)
* Tissue irritation
* Sore mouth
* Bone marrow suppression
* Hyperuricemia (high uric acid levels)
* Alopecia (hair loss)
* Cardiotoxicity (damage to the heart muscle)


Less common but potentially serious side effects may also occur.  It is crucial to promptly report any concerning side effects to a healthcare professional.

### How it Works
Aclarubicin is an anthracycline that works by intercalating into DNA, interfering with the processes of DNA replication and repair. It interacts with topoisomerases I and II, enzymes vital for maintaining DNA structure and function.  By inhibiting these enzymes, aclarubicin disrupts the ability of cancer cells to replicate and survive.  Importantly, aclarubicin shows less cardiotoxicity compared to some other anthracyclines like doxorubicin and daunorubicin.

### Precautions
* **Contraindications:** Aclarubicin is contraindicated in patients with severe heart disease, bone marrow depression, hypersensitivity to the drug, during pregnancy, and while breastfeeding.
* **Interactions:**  Concurrent use with certain other medications, such as mitomycin or nitrosoureas (due to increased myelosuppression risk), other cardiotoxic agents (increased risk of cardiotoxicity), and live vaccines (avoid concurrent use), must be avoided or carefully managed.  Aclarubicin can also affect the efficacy of drugs like digoxin, oral anticoagulants, phenytoin, and suxamethonium, requiring careful monitoring if used together.
* **Warnings:** Caution is advised in patients with a history of liver or kidney impairment, those receiving myocardial irradiation, undergoing radiotherapy, and elderly patients.

### FAQs
* **Q: How is aclarubicin administered?**
    * A: It's typically administered intravenously (IV) as part of a combination chemotherapy regimen.

* **Q: How is aclarubicin stored?**
    * A: Storage instructions should be followed as indicated on the medication packaging and as directed by the pharmacist.

* **Q: What should I do if I miss a dose?**
    * A: Never adjust your dosage or alter your treatment plan without consulting your doctor or oncologist.

* **Q: Are there long-term effects?**
    * A:  Like many chemotherapy drugs, aclarubicin can have long-term effects. Regular monitoring is crucial to detect and manage potential complications.  Discuss any concerns with your healthcare provider.

* **Q: Is aclarubicin suitable for all types of cancer?**
    * A: No, its primary use is in combination therapy for acute myeloid leukemia (AML). Its use in other cancers is limited.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The provided dosage information is not exhaustive and should not be used in place of guidance from your doctor or oncologist.
